INDEPENDENT THINKING. TRACEABLE EVIDENCE.Research edition · 29 October 2026
Modern DosingTHE PRACTITIONER’S PERSPECTIVEA clearer view of
the peptide economy ↗
The provider file / Dossier 7
RESEARCH DOSSIER / NOT AN ENDORSEMENT

OrderlyMeds

A dated business research record, with the original field-level evidence labels kept intact.

Source snapshot: 2026-10-29. “Verified” below is the source dataset author’s label—not an independent license, safety, quality or clinical audit by Modern Dosing. These pages are excluded from search indexing until reviewed.
Positioning & service claimsverified

'Doctor-led support at every step'; 'GLP-1 care, improved and simplified'; 'more accessible and honest'; 125k customers, 1M+ lbs lost; 4.6 Google; CMO-led screening.

Audienceread

Read: general adult weight-loss seekers, trust/safety framing, community ('a community you can count on').

Pricing & termspartial

Pricing page/homepage: compounded GLP-1 (semaglutide) $149/mo, starter as low as $74/mo (lowest dose, pay upfront; $149 for 2 months), $299 for 2 months at standard; compounded GLP-1/GIP (tirzepatide) $299/mo thereafter, $224/mo and $449/2 months tiers, $112/mo starter ($224 for 2 months); brand Zepbound $1,498/mo, Wegovy $1,839/mo. Includes provider consults/support plus free resource bundle ('$3,700 value'). Tier mapping on pricing page is ambiguous - verify before quoting.

Clinical relationshipsverified

Beluga Health Inc (wording in terms)

Pharmacy & fulfillmentverified

PerfectRx / PerfectionRx; ProRx; Casa; Pharmacy Hub; SmartPharmaRx

Advertising snapshotsnapshot

Google domain lookup (US, last 30 days): 91 ads. Recent domain-result ads observed under US / Last 30 days. Domain results include multiple advertiser accounts, and may include non-GLP products. sample last shown: Oct 11, 2026. Meta active exact-phrase keyword lookup: 0. No ads matched the checked brand/alias keyword queries. This is a library-search observation, not proof the brand runs no ads.

Founding yearverified

Company formed October 2023; consumer launch January 2024

Foundersverified

Chris Spears (founder/CEO)

Location & entity contextpartial

Atlanta, Georgia

Search visibility samplepartial

Free index sample: 3 domain-restricted pages and 3 brand+GLP results. Example pages: Online weight loss Medication (Injections); Semaglutide vs. Tirzepatide for Weight Loss: Which Wins?; New Patient Orientation: Your Guide to Starting GLP-1 Medications. No appearance in the checked 15-result samples for GLP-1 online weight loss, compounded semaglutide online, and compounded tirzepatide online.

THE MODERN DOSING WEEKLY

The peptide news
that changes your week.

Evidence-backed developments. The moves that matter. What each means for your practice or business—in one weekly email.